SCHEMBL7473906

SCHEMBL7473906

O=C(O)c1ccc2c3c(n(Cc4cc5c(cc4Cl)OCO5)c2c1)C(=O)CC3

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
KDM4E B2RXH2 2/20 0.43
FABP4 P15090 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SLC22A12 Q96S37 2/20 0.42
MAPK1 P28482 1/20 0.40
EDNRA P25101 5/20 0.38
EDNRB P24530 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
KCNH2 Q12809 1/20 0.35
MCHR1 Q99705 1/20 0.35
SRD5A2 P31213 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7426960 0.94 ALDH1A1 (0.51) ALDH1A1HPGDKDM4EFABP4TSHR
SCHEMBL7476678 0.91 SLC22A12 (0.39) ALDH1A1HPGDKDM4EFABP4TSHR
SCHEMBL7474496 0.89 MEN1 (0.43) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL7421878 0.85 KDM4E (0.41) ALDH1A1HPGDKDM4EFABP4TSHR
SCHEMBL7424979 0.83 FABP4 (0.51) ALDH1A1HPGDKDM4EFABP4TSHR
SCHEMBL7420612 0.83 ALDH1A1 (0.44) ALDH1A1HPGDKDM4ETSHRHSD17B10
SCHEMBL7707720 0.82 FABP4 (0.48) ALDH1A1HPGDKDM4EFABP4SLC22A12
SCHEMBL7416251 0.78 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EFABP4TSHR
SCHEMBL7371603 0.75 ALDH1A1 (0.58) ALDH1A1HPGDKDM4EFABP4TSHR
SCHEMBL7374915 0.75 IP6K1 (0.39) ALDH1A1HPGDKDM4EFABP4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed